Evidence map›Paper›PMID 41810340›Full record

ReviewWorld journal of clinical oncology2026

Intermittent fasting enhances cancer therapy

Mona Mohamed Ibrahim Abdalla, Payal Bhatnagar, Mohd Hazim Bin Zulkaflee, Abdul Malik Sahib Mohammed Irfan, Nabil Eid

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in World journal of clinical oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Mona Mohamed Ibrahim AbdallaDivision of Physiology, Department of Human Biology, School of Medicine, IMU University, Kuala Lumpur 57000, Malaysia.
Payal BhatnagarDepartment of Pharmaceutical Technology, School of Pharmacy, IMU University, Kuala Lumpur 57000, Malaysia.
Mohd Hazim Bin ZulkafleeDivision of Anatomy, Department of Human Biology, School of Medicine, IMU University, Kuala Lumpur 57000, Malaysia.
Abdul Malik Sahib Mohammed IrfanDivision of Physiology, Department of Human Biology, School of Medicine, IMU University, Kuala Lumpur 57000, Malaysia.
Nabil EidDivision of Anatomy, Department of Human Biology, School of Medicine, IMU University, Kuala Lumpur 57000, Malaysia. nabilsaleheid@imu.edu.my.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Macroautophagy (hereafter referred to as autophagy) is a lysosomal degradation pathway that clears and recycles cytosolic oncogenic factors, excess lipids, and damaged mitochondria, thereby potentially preventing cancer initiation. Recent studies using

Indexed as

AutophagyCancerChemotherapyInflammationIntermittent fastingMetabolic diseasesObesity

Identifiers

PMID41810340
PMCPMC12968541

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.